Bozhon Precision Industry Technology (688097.SH) controlling shareholder and concerted action person intend to transfer 5.426% of the company's shares.
Bozhong Precision (688097.SH) announced that the company's controlling shareholder, Jiangsu Bozhong Intelligent Technology Group Co., Ltd. (...)
Bozhon Precision Industry Technology (688097.SH) announced that its controlling shareholder, Jiangsu Bozhon Intelligent Technology Group Co., Ltd. (referred to as Bozhon Group), and its concerted action party Suzhou Zhong Er Equity Investment Partnership Enterprise (Limited Partnership) (referred to as "Suzhou Zhong Er") have signed a share transfer agreement with Tianjin Xinsci Hongchuang Equity Investment Partnership Enterprise (Limited Partnership) (referred to as "Xinsci Hongchuang"). They plan to transfer 24,235,107 unrestricted tradable shares held by Suzhou Zhong Er (accounting for 5.426% of the current total share capital of the company) to Xinsci Hongchuang. After this agreement, Suzhou Zhong Er will still directly hold 29.216% of the company's shares. Xinsci Hongchuang will directly hold 5.426% of the company's shares.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025